C4 Therapeutics, Inc.. (1/4/19). "Press Release: Roche Degrader-based Medicines Collaboration. C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche". Watertown, MA. |
2019-01-04 |
Rentschler Biopharma SE. (1/3/19). "Press Release: Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site". Laupheim & Milford, MA. |
2019-01-03 |
UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY. |
2019-01-03 |
ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin. |
2019-01-03 |
Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. |
2019-01-03 |
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim. |
2019-01-03 |
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA. |
2019-01-03 |
Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich. |
2019-01-03 |
InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY. |
2019-01-03 |
ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne. |
2019-01-03 |
Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent. |
2019-01-03 |
Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna. |
2019-01-02 |
Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2019-01-02 |
Novartis AG. (12/21/18). "Press Release: Novartis Successfully Completes Acquisition of Endocyte". Basel. |
2018-12-21 |
Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. |
2018-12-21 |
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. |
2018-12-21 |
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. |
2018-12-20 |
Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. |
2018-12-20 |
Bruker Corporation. (12/20/18). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. |
2018-12-20 |
Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. |
2018-12-20 |
SHS Gesellschaft für Beteiligungsmanagement mbH. (12/20/18). "Press Release: SHS Invests in Swiss Life Science Company Evitria AG". Tübingen & Schlieren. |
2018-12-20 |
Intrexon Corporation. (12/20/18). "Press Release: Intrexon and Merck KGaA, Darmstadt, Germany, Announce Agreement Realizing Precigen's Vision for Full Developmental Autonomy of its CAR-T Program". Germantown, MD. |
2018-12-20 |
AC Immune S.A.. (12/19/18). "Press Release: AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership". Lausanne & Shanghai. |
2018-12-19 |
Annexon Biosciences Inc.. (12/19/18). "Press Release: Annexon Biosciences Closes $75 Million Financing". South San Francisco, CA. |
2018-12-19 |
Cellestia Biotech AG. (12/19/18). "Press Release: Cellestia Biotech AG Successfully Closes Series A Financing Round, Raising a Total of CHF 20 Million". Basel. |
2018-12-19 |
Medigene AG. (12/19/18). "Press Release: Medigene Publishes Topline Interim Data from Ongoing Phase I/II Clinical Trial with DC Vaccines in AML Patients". Martinsried. |
2018-12-19 |
Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. |
2018-12-18 |
Bruker Corporation. (12/18/18). "Press Release: Bruker Completes the Acquisition of Alicona Imaging GmbH". Billerica, MA. |
2018-12-18 |
High-Tech Gründerfonds Management GmbH. (12/18/18). "Press Release: High-Tech Gründerfonds and Think.Health Ventures together with Business Angels Invest 3.3 Million Euros in a Series A for the Growth of PreOmics in Martinsried, Germany". |
2018-12-18 |
Amgen Inc.. (12/18/18). "Press Release: Amgen and Molecular Partners Announce Strategic Collaboration In Immuno-Oncology". Thousand Oaks, CA & Schlieren. |
2018-12-18 |
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. |
2018-12-18 |
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". |
2018-12-18 |
Versameb AG. (12/18/18). "Press Release: Versameb Ltd Raises CHF 5.3 Million for the Development of mRNA Therapies in Regenerative Medicine". Basel. |
2018-12-18 |
Rentschler Biopharma SE. (12/17/18). "Press Release: Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc". Laupheim & Milford, MA. |
2018-12-17 |
Selexis S.A.. (12/17/18). "Press Release: TeneoBio and Selexis Enter Second Services Agreement to Develop Research Cell Banks". Geneva & Menlo Park, CA. |
2018-12-17 |
Seer, Inc.. (12/17/18). "Press Release: Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases". South San Francisco, CA. |
2018-12-17 |
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. |
2018-12-17 |
Hookipa Pharma Inc.. (12/17/18). "Press Release: Hookipa Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus". New York, NY & Vienna. |
2018-12-17 |
Virion Biotherapeutics Ltd.. (12/17/18). "Press Release: Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing". London. |
2018-12-17 |
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. |
2018-12-14 |
BRAIN AG. (12/14/18). "Press Release: BRAIN Achieves Double-digit Growth in Total Operating Performance and Revenues in the 2017/18 Financial Year". Zwingenberg. |
2018-12-14 |
Santhera Pharmaceuticals Holding AG. (12/14/18). "Press Release: Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license". Pratteln. |
2018-12-14 |
Noxxon Pharma N.V.. (12/14/18). "Press Release: Noxxon Announces Key Findings that NOX-A12 plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients". Berlin. |
2018-12-14 |
Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-12-13 |
Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. |
2018-12-13 |
Third Rock Ventures, LLC. (12/13/18). "Press Release: Third Rock Ventures Names Christoph Lengauer, Ph.D., and Jeffrey Tong, Ph.D., as Partners". Boston, MA. |
2018-12-13 |
Lead Discovery Center GmbH. (12/13/18). "Press Release: LDC and the University of Duisburg-Essen Receive EUR 905,000 for the Development of New Therapies for Age-related Blindness". Dortmund. |
2018-12-13 |
c-LEcta GmbH. (12/13/18). "Press Release: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019". |
2018-12-13 |
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. |
2018-12-13 |
ERS Genomics Ltd.. (12/13/18). "Press Release: ERS Genomics and Lonza Enter into CRISPR/Cas9 Technology Licensing Deal". Dublin. |
2018-12-13 |
Santhera Pharmaceuticals Holding AG. (12/12/18). "Press Release: Santhera Announces Financial Results for the First Nine Months of 2018". Pratteln. |
2018-12-12 |
AC Immune S.A.. (12/12/18). "Press Release: AC Immune and Lilly Announce License and Collaboration Agreement". Lausanne & Indianapolis, IN. |
2018-12-12 |
SGS S.A.. (12/12/18). "Press Release: SGS Invests in Imprint Analytics, Austria". |
2018-12-12 |
BRAIN AG. (12/11/18). "Press Release: Global Beverage Company Joins BRAIN’s Newly Established FRESCO Program for Nature-based Preservation Ingredients". Zwingenberg & Potsdam. |
2018-12-11 |
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. |
2018-12-11 |
High-Tech Gründerfonds Management GmbH. (12/11/18). "Press Release: High-Tech Gründerfonds and Technologiegründerfonds Sachsen Support Enabling Human Biology in vitro with an Investment in Dresden Start-up DenovoMatrix". |
2018-12-11 |
Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA. |
2018-12-10 |
Centogene AG. (12/10/18). "Press Release: Centogene and Chiesi Germany Sign Strategic Alliance in Lysosomal Storage Disorders". Rostock & Hamburg. |
2018-12-10 |
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. |
2018-12-10 |
Lonza Group AG. (12/10/18). "Press Release: Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution". Basel & Guangzhou. |
2018-12-10 |
Roche. (12/10/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. |
2018-12-10 |
Bruker Corporation. (12/10/18). "Press Release: Bruker Introduces Advanced Illumination for Next-Generation Lattice Light-Sheet Microscopy". San Diego, CA & Abbott Park, IL. |
2018-12-10 |
Novartis AG. (12/10/18). "Press Release: Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O to Treat Opioid Use Disorder". Holzkirchen. |
2018-12-10 |
MyNewGut Project. (12/10/18). "Press Release: Gut Microbiota Linked to Obesity and Mental Disorders, EU-funded Project »MyNewGut« Finds". |
2018-12-10 |
Alnylam Pharmaceuticals, Inc.. (12/10/18). "Press Release: Alnylam Announces Settlement of Litigation with Silence Therapeutics". Cambridge, MA. |
2018-12-10 |
AC Immune S.A.. (12/7/18). "Press Release: In Memoriam – Dr. Andreas Muhs CSO, Scientific Leader and Friend Has Passed Away". Lausanne. |
2018-12-07 |
Merck KGaA. (12/6/18). "Press Release: Merck in Agreement with Cyclica for AI-augmented Screening Platform to Expand Research Capabilities". Darmstadt. |
2018-12-06 |
Qiagen N.V.. (12/6/18). "Press Release: Qiagen Announces New Collaboration to Develop Companion Diagnostic to Guide Treatment for Patients with PIK3CA-mutated Advanced Breast Cancer". Germantown, MD & Hilden. |
2018-12-06 |
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. |
2018-12-06 |
Novartis AG. (12/6/18). "Press Release: Novartis Investigational BYL719 (alpelisib) plus Fulvestrant Consistently Improved PFS in Patients with PIK3CA Mutated HR+/HER2- Advanced Breast Cancer in New SOLAR-1 Analyses". Basel. |
2018-12-06 |
Confo Therapeutics N.V.. (12/6/18). "Press Release: Confo Therapeutics Appoints Frank Landolt as Its Chief Counsel Legal & Intellectual Property". Ghent. |
2018-12-06 |
LaVoieHealthScience (LHS). (12/5/18). "Press Release: Sirion Biotech Names LaVoieHealthScience as Strategic Communications Agency of Record. SIRION Biotech Plans Path for U.S. Market Expansion". Boston & Martinsried. |
2018-12-05 |
Evotec AG. (12/4/18). "Press Release: Evotec and Leo Pharma Form Drug Discovery Alliance Targeting Dermatological Conditions". Hamburg & Ballerup. |
2018-12-04 |
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour |
2018-12-04 |
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. |
2018-12-04 |
Alacris Theranostics GmbH. (12/4/18). "Press Release: Alacris Theranostics startet Seedmatch-Crowdfunding-Kampagne für einzigartige computergestützte Tumoranalyse zur Optimierung von Krebstherapien". |
2018-12-04 |
Protagen AG. (12/4/18). "Press Release: The EORTC Brain Tumor Group and Protagen AG Announce Their Collaboration to Investigate the Immuno-competence of Long-term Glioblastoma Survivors". |
2018-12-04 |
Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. |
2018-12-03 |
Genedata AG. (12/3/18). "Press Release: Genedata Opens New Subsidiary in Singapore to Support Growing Business in Asia and Australia". Singapore. |
2018-12-03 |
Spindiag GmbH. (12/3/18). "Press Release: SpinDiag Closes Second Financing Round of EUR 3.0 million (USD 3.4 million) to Complete Product Development of Its Point-of-Care Screening System for Antibiotic-resistant Bacteria". Freiburg. |
2018-12-03 |
Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. |
2018-12-03 |
CMS Hasche Sigle. (12/3/18). "Press Release: CMS berät Wellington und HBM als Lead Investoren der Serie D-Finanzierungsrunde der Adrenomed". München. |
2018-12-03 |
Qiagen N.V.. (11/30/18). "Press Release: Qiagen and NeoGenomics Collaborate to Offer Cancer Patients Day-One Access to Innovative Companion Diagnostics for Newly Approved Drugs". Hilden, Germantown, MD & Fort Myers, FL. |
2018-11-30 |
Marinomed Biotech AG. (11/29/18). "Press Release: Marinomed Suspends Offer Period of the Current IPO [Adhoc-News]". |
2018-11-29 |
Forbion Capital Partners. (11/29/18). "Press Release: Forbion Appoints Dr. Carlo Incerti as Operating Partner". Naarden & Munich. |
2018-11-29 |
Marinomed Biotech AG. (11/28/18). "Press Release: Viennese Biotech Company Marinomed Demonstrates the Benefits of Its Patented Marinosolv Technology". |
2018-11-28 |
Qiagen N.V.. (11/28/18). "Press Release: Qiagen Extends Comprehensive Offering for Cervical Cancer Screening with European Launch of QIAscreen HPV PCR Test". Hilden. |
2018-11-28 |
Hookipa Pharma Inc.. (11/28/18). "Press Release: Hookipa and DarwinHealth Enter into a Research Collaboration and License Agreement". New York, NY & Vienna. |
2018-11-28 |
Jecure Therapeutics Inc.. (11/27/18). "Press Release: Genentech Acquires Jecure Therapeutics". San Diego, CA. |
2018-11-27 |
German Accelerator Life Sciences. (11/27/18). "Press Release: German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round". Freiburg & Cambridge, MA. |
2018-11-27 |
Arsanis, Inc.. (11/27/18). "Press Release: Arsanis and X4 Pharmaceuticals Agree to Merger". Cambridge, MA, Waltham, MA & Vienna. |
2018-11-27 |
Inkef Capital B.V.. (11/27/18). "Press Release: Inkef Capital Appoints Roel Bulthuis as Managing Director to Co-Manage Eur 500m Fund". Amsterdam. |
2018-11-27 |
Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug. |
2018-11-26 |
Bayer Corporation. (11/26/18). "Press Release: FDA Approves Vitrakvi (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion". Whippany, NJ & Stamford, CT. |
2018-11-26 |
MorphoSys AG. (11/26/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis". Planegg. |
2018-11-26 |
BRAIN AG. (11/26/18). "Press Release: Suntory Beverage & Food Europe and BRAIN AG Start Joint Development Program". Zwingenberg & Uxbridge. |
2018-11-26 |
Cyclica Inc.. (11/26/18). "Press Release: Cyclica Drives Drug Discovery through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer". Toronto. |
2018-11-26 |
Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia, |
2018-11-23 |
Merck KGaA. (11/23/18). "Press Release: Merck Appoints Jasper Bos as Managing Director of M Ventures". Darmstadt. |
2018-11-23 |
Curetis N.V.. (11/23/18). "Press Release: Curetis Announces Financial Results for the First Nine Months of 2018". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-11-23 |